✦ LIBER ✦

Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers

✍ Scribed by Larissa J. Lee; Brian Alexander; Stuart J. Schnitt; Amy Comander; Bridget Gallagher; Judy E. Garber; Nadine Tung

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 154 KB
Volume: 117
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25911

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lymphocyte radiosensitivity in BRCA1 and

Lymphocyte radiosensitivity in BRCA1 and BRCA2 mutation carriers and implications for breast cancer susceptibility

✍ Julian Barwell; Laurent Pangon; Anne Georgiou; Ian Kesterton; Caroline Langman; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 336 KB 👁 1 views

## Abstract There is conflicting evidence as to whether individuals who are heterozygous for germ‐line __BRCA1__ or __BRCA2__ mutations have an altered phenotypic cellular response to irradiation. To investigate this, chromosome breakage and apoptotic response were measured after irradiation in per

Impact of body mass index on clinical ou

Impact of body mass index on clinical outcomes in triple-negative breast cancer

✍ Foluso O. Ademuyiwa; Adrienne Groman; Tracey O'Connor; Christine Ambrosone; Nanc 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB 👁 1 views

Outcomes of breast cancer patients with

Outcomes of breast cancer patients with and without BRCA1/2 mutations

✍ Michael Fatouros; Dimosthenis Ziogas; Dimitrios H. Roukos 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 50 KB 👁 1 views

Effect of pregnancy as a risk factor for

Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers

✍ Carey A. Cullinane; Jan Lubinski; Susan L. Neuhausen; Parviz Ghadirian; Henry T. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 69 KB 👁 1 views

## Abstract Early age at first birth and multiparity have been associated with a decrease in the risk of breast cancer in women in the general population. We examined whether this relationship is also present in women at high risk of breast cancer due to the presence of a mutation in either of the

Breast cancer risk in BRCA1 and BRCA2 mu

Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene

✍ David J. Hughes; Sophie M. Ginolhac; Isabelle Coupier; Laure Barjhoux; Valérie G 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 89 KB 👁 2 views

## Abstract Marked variation in phenotypic expression among __BRCA1__ and __BRCA2__ mutation carriers may be partly explained by modifier genes that influence mutation penetrance. Variation in CAG/CAA repeat lengths coding for stretches of glutamines in the C‐terminus of the AIB1 protein (amplified

Ovarian cancer susceptibility alleles an

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

✍ Susan J. Ramus; Antonis C. Antoniou; Karoline B. Kuchenbaecker; Penny Soucy; Jon 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB 👁 1 views

Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian cancer. A genome-wide association study (GWAS) identified six alleles associated with risk of ovarian cancer for women in the general population. We evaluated four of these loci as potential modifiers of